San Diego’s Genomatica, the industrial biotechnology startup, says it has agreed to establish a joint venture with Novamont, the Italian bio-plastic producer, to develop the first industrial plant in Europe to produce butanediol (BDO) from renewable feedstocks. Novamont plans to use the estimated 40 million pounds per year output to meet the increasing demand for its products. Genomatica will retain an option for a portion of the BDO production.
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace
From Our Partners · Special Report
Advice for funding and future transformational opportunities
